In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing Phas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results